dicloxacillin has been researched along with amphotericin b in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Balish, E; Chan, CK | 1 |
| Bourantas, C; Chaliasos, N; Kritikou, E; Lapatsanis, P | 1 |
| Azeredo, J; Cerca, N; Henriques, M; Oliveira, R | 1 |
1 review(s) available for dicloxacillin and amphotericin b
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for dicloxacillin and amphotericin b
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Inhibition of granulocyte phagocytosis of Candida albicans by amphotericin B.
Topics: Amphotericin B; Candida albicans; Chloramphenicol; Dicloxacillin; Gentamicins; Humans; Neutrophils; Phagocytosis | 1978 |
A 7-month-old girl with fever and bleeding.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Dicloxacillin; Female; Humans; Infant; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin Diseases | 1996 |
Influence of sub-inhibitory concentrations of antimicrobial agents on biofilm formation in indwelling medical devices.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Biofilms; Candida; Cefazolin; Dicloxacillin; Fluconazole; Humans; Staphylococcus epidermidis; Vancomycin | 2005 |